Five Years after Frontline Tyrosine-Kinase Inhibitor (TKI) Treatment Initiation for Chronic Myeloid Leukemia: What Does It Happen in a Real-Life Setting?

Daniela De Benedittis, Roberto Latagliata, Ida Carmosino et al.|Blood|2018

Cited by 0